fda warning letters compounded tirzepatide 2024 2025 Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding Why the FDA Issued 30
Description
For our patientsparticularly those with type 2 diabetes or insulin resistancetirzepatide can be especially valuable
The long-term weight management picture has one part that doesn't make it into most ads: stopping GLP-1 therapy is consistently associated with weight regain in clinical extension studies
At $1,100 per month, a year of brand-name Mounjaro costs $13,200
10.1186/s12933-023-01797-5 [DOI] [PMC free article] [PubMed] 66.Thomas MK, Nikooienejad A, Bray R, Cui X, Wilson J, Duffin K, Milicevic Z, Haupt A, Robins DA
Sugary cocktails carry additional blood sugar risks
